Client News

ReproNovo Announces Clinical Trial Approval Notice for RPN-001 in China

Abivax Announces Acceptance of Additional Late-Breaking Abstract from the ABTECT Phase 3 Induction Trials to be Presented at 2025 United European Gastroenterology (UEG) Meeting

Heidelberg Pharma Advances to Cohort 9 in Phase I/IIa Trial of Lead ATAC Candidate HDP-101 in Multiple Myeloma

AL-S Pharma Appoints Internationally Recognized Neurologist and Clinical Trial Expert Prof. Dr. Angela Genge as Chief Medical Officer

Heidelberg Pharma Significantly Reduces Operating Costs and Focuses on Lead ADC Candidate HDP-101 Due to Delayed Milestone Payment

CARBIOS presents its 2025 half-year results and confirms its objective to build a PET biorecycling plant, with a revised timeline

Abivax Announces Presentation of Late-Breaking Abstract for Obefazimod from the ABTECT Phase 3 Induction Trials at 2025 United European Gastroenterology (UEG) Meeting

Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland – Company Provides Update on eAArly DETECT 2 Study

HeartBeat.bio Joins Forces with Boehringer Ingelheim to Advance Gene Therapies for Inherited Heart Muscle Disorders

DEBRA Research and Nonsense Therapeutics Launch ReadOn Therapeutics to Accelerate Novel Therapies for Epidermolysis Bullosa